66 related articles for article (PubMed ID: 1685823)
1. [Changes in cell-mediated immune reactions in Crohn's disease].
Ecker KW; Güremen A; Feifel G
Z Gastroenterol; 1991 Oct; 29(10):529-32. PubMed ID: 1685823
[TBL] [Abstract][Full Text] [Related]
2. Immunoresponsiveness in ulcerative colitis and Crohn's disease--effect of colectomy and suppression of disease activity.
Lyanga J; Davis P; Thomson AB
West J Med; 1988 Apr; 148(4):421-5. PubMed ID: 3388844
[TBL] [Abstract][Full Text] [Related]
3. Prior bowel resections, perianal disease, and a high initial Crohn's disease activity index are associated with corticosteroid resistance in active Crohn's disease.
Gelbmann CM; Rogler G; Gross V; Gierend M; Bregenzer N; Andus T; Schölmerich J
Am J Gastroenterol; 2002 Jun; 97(6):1438-45. PubMed ID: 12094862
[TBL] [Abstract][Full Text] [Related]
4. Malnutrition and impaired muscle strength in patients with Crohn's disease and ulcerative colitis in remission.
Valentini L; Schaper L; Buning C; Hengstermann S; Koernicke T; Tillinger W; Guglielmi FW; Norman K; Buhner S; Ockenga J; Pirlich M; Lochs H
Nutrition; 2008; 24(7-8):694-702. PubMed ID: 18499398
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome of surgically treated Crohn's colitis: a prospective study.
Fichera A; McCormack R; Rubin MA; Hurst RD; Michelassi F
Dis Colon Rectum; 2005 May; 48(5):963-9. PubMed ID: 15785882
[TBL] [Abstract][Full Text] [Related]
6. Studies of cell-mediated immunity in patients with Crohn's disease.
Surrenti C; Ramarli D; Casini A; Scartabelli S; Campi P; Fani A; Nieri S
Hepatogastroenterology; 1981 Jun; 28(3):157-9. PubMed ID: 7250897
[TBL] [Abstract][Full Text] [Related]
7. Feasibility and effectiveness of a defined-formula diet regimen in treating active Crohn's disease. European Cooperative Crohn's Disease Study III.
Malchow H; Steinhardt HJ; Lorenz-Meyer H; Strohm WD; Rasmussen S; Sommer H; Jarnum S; Brandes JW; Leonhardt H; Ewe K
Scand J Gastroenterol; 1990 Mar; 25(3):235-44. PubMed ID: 1969678
[TBL] [Abstract][Full Text] [Related]
8. Immune activation and nutritional status in adult Crohn's disease patients.
Reimund JM; Arondel Y; Escalin G; Finck G; Baumann R; Duclos B
Dig Liver Dis; 2005 Jun; 37(6):424-31. PubMed ID: 15893281
[TBL] [Abstract][Full Text] [Related]
9. Current status of drug therapy for inflammatory bowel disease.
Peppercorn MA
Compr Ther; 1985 Dec; 11(12):14-9. PubMed ID: 2866866
[TBL] [Abstract][Full Text] [Related]
10. European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment.
Malchow H; Ewe K; Brandes JW; Goebell H; Ehms H; Sommer H; Jesdinsky H
Gastroenterology; 1984 Feb; 86(2):249-66. PubMed ID: 6140202
[TBL] [Abstract][Full Text] [Related]
11. Immunoglobulin G subclasses in Crohn's disease with and without bowel resection.
Bures J; Tichý M; Horácek J; Král B; Sobotka L; Cervenka B; Zadák Z; Komárková O; Fixa B; Pidrman V
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1993; 36(3):139-47. PubMed ID: 8159910
[TBL] [Abstract][Full Text] [Related]
12. Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital.
Bernstein CN; Papineau N; Zajaczkowski J; Rawsthorne P; Okrusko G; Blanchard JF
Am J Gastroenterol; 2000 Mar; 95(3):677-83. PubMed ID: 10710056
[TBL] [Abstract][Full Text] [Related]
13. Peripheral blood mononuclear cells from patients with inflammatory bowel disease exhibit normal function in the allogeneic and autologous mixed leukocyte reaction and cell-mediated lympholysis.
MacDermott RP; Bragdon MJ; Thurmond RD
Gastroenterology; 1984 Mar; 86(3):476-84. PubMed ID: 6229444
[TBL] [Abstract][Full Text] [Related]
14. [The role of nutritional status on serum immunoglobulins, body weight and postoperative infectious-related complications in patients with Crohn's disease receiving perioperative parenteral nutrition].
Yao GX; Wang XR; Jiang ZM; Zhang SY; Ma EL; Ni AP
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Apr; 24(2):181-4. PubMed ID: 12905799
[TBL] [Abstract][Full Text] [Related]
15. Effect of pregnancy on the clinical course of a cohort of women with inflammatory bowel disease.
Castiglione F; Pignata S; Morace F; Sarubbi A; Baratta MA; D'Agostino L; D'Arienzo A; Mazzacca G
Ital J Gastroenterol; 1996 May; 28(4):199-204. PubMed ID: 8842834
[TBL] [Abstract][Full Text] [Related]
16. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease.
Borrelli O; Bascietto C; Viola F; Bueno de Mesquita M; Barbato M; Mancini V; Bosco S; Cucchiara S
Dig Liver Dis; 2004 May; 36(5):342-7. PubMed ID: 15191204
[TBL] [Abstract][Full Text] [Related]
17. Laboratory markers predict bone loss in Crohn's disease: relationship to blood mononuclear cell function and nutritional status.
Trebble TM; Wootton SA; Stroud MA; Mullee MA; Calder PC; Fine DR; Moniz C; Arden NK
Aliment Pharmacol Ther; 2004 May; 19(10):1063-71. PubMed ID: 15142195
[TBL] [Abstract][Full Text] [Related]
18. Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease.
Dotan I; Fishman S; Dgani Y; Schwartz M; Karban A; Lerner A; Weishauss O; Spector L; Shtevi A; Altstock RT; Dotan N; Halpern Z
Gastroenterology; 2006 Aug; 131(2):366-78. PubMed ID: 16890590
[TBL] [Abstract][Full Text] [Related]
19. Therapeutical experiments in ulcerative colitis and Crohn's disease.
Nagy G; Prónay G; Ujszászy L
Acta Med Hung; 1985; 42(3-4):163-74. PubMed ID: 2869469
[TBL] [Abstract][Full Text] [Related]
20. Intestinal mucosa diamine oxidase activity reflects intestinal involvement in Crohn's disease.
Thompson JS; Burnett DA; Markin RS; Vaughan WP
Am J Gastroenterol; 1988 Jul; 83(7):756-60. PubMed ID: 3132852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
